The U.S. home infusion therapy market is projected to grow significantly from USD 19.56 billion in 2025 to USD 36.88 billion by 2034, at a CAGR of 7.3%. This growth is driven by rising cases of chronic diseases, technological advancements in infusion devices, and the shift toward cost-effective home-based treatments. Increasing demand for intravenous medications, such as antibiotics, nutrition, and specialty drugs like immunoglobulins, is fueling this trend. Infusion pumps continue to dominate the product segment due to their safety, convenience, and accuracy in drug delivery.
Download the Free Sample Now and Get the Complete Report and Insights of this Market Easily @ https://www.towardshealthcare.com/download-sample/5102
Headquarters: Bannockburn, Illinois, U.S.
Strengths:
●Largest independent provider of home and alternate site infusion services in the U.S.
●Nationwide coverage with over 100 infusion sites.
Key Products/Services:
●IV antibiotics, TPN (Total Parenteral Nutrition), hydration therapy, pain management, and specialty medications.
Headquarters: Deerfield, Illinois, U.S.
Strengths:
●Strong R&D and global reach in infusion systems.
●Focus on advancing infusion pump technologies.
Key Products/Services:
●Sigma Spectrum Infusion System, IV solutions, and devices for critical care and nutrition therapy.
Headquarters: Bethlehem, Pennsylvania, U.S.
Strengths:
●Known for high-quality medical devices and fluid therapy products.
●Focus on reducing infusion-related errors.
Key Products/Services:
●Infusomat Space pumps, intravenous solutions, and drug delivery systems.
Headquarters: Lake Zurich, Illinois, U.S.
Strengths:
●Division of global healthcare leader Fresenius Group.
●Strong focus on oncology, critical care, and parenteral nutrition.
Key Products/Services:
●IV drugs, clinical nutrition, infusion therapy systems.
Headquarters: Woonsocket, Rhode Island, U.S.
Strengths:
●Leverages CVS retail pharmacy network and MinuteClinics.
●Integrated services combining pharmacy, insurance, and infusion.
Key Products/Services:
●Infusion therapy for chronic and acute conditions, including hemophilia, immune deficiencies, and more.
Headquarters: San Clemente, California, U.S.
Strengths:
●Specializes in safe and precise infusion systems.
●Supplies key components like needle-free connectors and IV sets.
Key Products/Services:
●Plum 360 infusion system, IV consumables, and oncology delivery solutions.
Headquarters: Minneapolis, Minnesota, U.S.
Strengths:
●Strong reputation in infusion and patient monitoring technologies.
●Now under ICU Medical, expanding portfolio.
Key Products/Services:
●CADD infusion pumps, Medfusion syringe pumps, and IV accessories.
Headquarters: Baton Rouge, Louisiana, U.S.
Strengths:
●Leading provider of home health and hospice services.
●Expanding into infusion therapy with skilled nursing.
Key Products/Services:
●Infusion administration via in-home nursing, supportive care, chronic disease management.
●Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5102
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
The global regenerative medicine market is expected to grow significantly from USD 24.39 billion in 2025 to USD 139.70 billion… Read More
The global brain-computer interfaces market is projected to grow significantly from USD 3.21 billion in 2025 to USD 12.87 billion… Read More
The U.S. home infusion therapy market is projected to grow from USD 19.56 billion in 2025 to USD 36.88 billion… Read More
The global knee replacement prosthesis market, valued at approximately US $12.1 billion in 2023, is projected to nearly double to US $22.73 billion by… Read More
The global regenerative medicine market is expected to surge from USD 24.39 billion in 2025 to around USD 139.70 billion by 2034, reflecting a… Read More
The global Brain‑Computer Interfaces market is poised for substantial expansion, projected to grow from approximately US $3.21 billion in 2025 to US $12.87 billion… Read More